Biogen Inc
Change company Symbol lookup
Select an option...
BIIB Biogen Inc
EOG EOG Resources Inc
POL PolyOne Corp
HAS Hasbro Inc
JBLU JetBlue Airways Corp
CDNS Cadence Design Systems Inc
IVAC Intevac Inc
HLIT Harmonic Inc
MPWR Monolithic Power Systems Inc
MXIM Maxim Integrated Products Inc
Go

Health Care : Biotechnology | Large Cap ValueCompany profile

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Price
Delayed
$287.51
Day's Change
64.00 (28.63%)
Bid
--
Ask
--
B/A Size
--
Day's High
318.00
Day's Low
279.16
Volume
(Heavy Day)

Today's volume of 19,168,390 shares is on pace to be much greater than BIIB's 10-day average volume of 2,133,791 shares.

19,168,390
  • Prev Close
    223.51
  • Today's Open
    310.00
  • Day's Range
    279.16-318.00
  • Avg Vol (10-day)
    2.1M
  • Last (time)
    2:40p ET 10/22/19
  • Last (size)
    500
  • 52-Wk Range
    215.78 - 344.00
    LowHigh
  • (01/23/19 - 09/04/19)
    16.42%
  • 44.1%
  • Market Cap
    53.1B
  • Shares Outstanding
    184.4M
  • 27.00
  • 8.28x
  • No dividend
  • Ex-dividend
    No dividend
  • 1.0
  • 88.62
  • (% of float 09/30/19)
    1.94

Latest News

October 22, 2019
2:25 pm ET
MarketWatch
1:09 pm ET
MarketWatch
11:49 am ET
MarketWatch
11:08 am ET
MarketWatch
11:08 am ET
MarketWatch
11:08 am ET
MarketWatch
9:40 am ET
Zacks
9:23 am ET
Zacks
6:57 am ET
MarketWatch
6:57 am ET
MarketWatch
6:56 am ET
MarketWatch
6:30 am ET
Globe Newswire
October 21, 2019
7:30 am ET
Globe Newswire
October 12, 2019
12:26 pm ET
MarketWatch
October 02, 2019
11:21 am ET
MarketWatch
7:30 am ET
Globe Newswire
October 01, 2019
8:07 am ET
Globe Newswire
8:06 am ET
MarketWatch
8:02 am ET
MarketWatch
September 23, 2019
3:00 am ET
Globe Newswire
September 18, 2019
7:30 am ET
Globe Newswire
September 17, 2019
7:30 am ET
Globe Newswire
September 16, 2019
11:30 am ET
PR Newswire
September 13, 2019
8:19 am ET
MarketWatch
8:05 am ET
MarketWatch
8:00 am ET
PR Newswire
September 12, 2019
5:00 am ET
Globe Newswire
September 11, 2019
5:00 am ET
Globe Newswire
August 30, 2019
7:08 am ET
MarketWatch
August 21, 2019
8:30 am ET
PR Newswire
August 20, 2019
7:30 am ET
Globe Newswire
August 16, 2019
10:39 am ET
MarketWatch
July 30, 2019
7:30 am ET
Globe Newswire
7:30 am ET
PR Newswire
July 24, 2019
9:36 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.